Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Rhabdomyosarcoma (RMS) comprises of heterogeneous group of neoplasms that occasionally express epithelial markers on immunohistochemistry (IHC). We herein report the case of a patient who developed RMS of the skull with EWSR1 fusion and anaplastic lymphoma kinase (ALK) and cytokeratin expression as cytomorphologic features. A 40-year-old man presented with a mass in his forehead. Surgical resection was performed, during which intraoperative frozen specimens were obtained. Squash cytology showed scattered or clustered spindle and epithelioid cells. IHC revealed that the resected tumor cells were positive for desmin, MyoD1, cytokeratin AE1/ AE3, and ALK. Although EWSR1 rearrangement was identified on fluorescence in situ hybridization, ALK, and TFCP2 rearrangement were not noted. Despite providing adjuvant chemoradiation therapy, the patient died of tumor progression 10 months after diagnosis. We emphasize that a subset of RMS can express cytokeratin and show characteristic histomorphology, implying the need for specific molecular examination.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424198PMC
http://dx.doi.org/10.4132/jptm.2024.08.15DOI Listing

Publication Analysis

Top Keywords

skull ewsr1
8
ewsr1 fusion
8
alk cytokeratin
8
cytokeratin expression
8
rhabdomyosarcoma skull
4
alk
4
fusion alk
4
cytokeratin
4
expression case
4
case report
4

Similar Publications

The 5th edition of the World Health Organization (WHO) classification of soft tissue and bone has recognized three distinct groups among Ewing-like sarcomas, namely, CIC-rearranged sarcoma, sarcomas with genetic alterations, and round cell sarcomas with EWSR1:: non-ETS fusions. Sarcomas with genetic alterations are a distinct clinicopathological group of high-grade tumors, representing 5% of small round cell tumors. BCOR-ITD rearranged tumors commonly manifest as spindle cell sarcomas and many of them display low cellularity with monomorphous cell morphology and myxoid background resembling benign fibroblastic tumors.

View Article and Find Full Text PDF

A Rare Case of Ewing Sarcoma of the Left Ethmoid Sinus With Orbital Extension.

Head Neck

February 2025

Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medicine, New York, New York, USA.

Background: Ewing sarcoma (ES) of the ethmoid sinus with orbital involvement in an adult is very rare, with 16 reported cases in the literature. Immunohistochemical studies show small blue round cells positive for CD99 and fluorescence in situ hybridization (FISH) testing reveals positivity for the EWSR1 gene.

Methods: A 38-year-old male with a diagnosis of ES of the ethmoid sinus presented with left-sided periorbital pain and edema, rhinorrhea, and proptosis.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study reports a 40-year-old man with RMS in his forehead who had specific genetic markers and cellular characteristics identified through imaging techniques and tests.
  • * Despite undergoing surgery and additional treatment, the patient unfortunately died of cancer progression 10 months after his diagnosis, highlighting the importance of detailed molecular analysis for effective treatment.
View Article and Find Full Text PDF

Primary extraosseous intracranial Ewing sarcoma (ES) is an extremely rare disease, limited to the pediatric population, that primarily originates in the skull. Here, we present an unusual case of adult Ewing's sarcoma originating from the brain parenchyma. The 50-year-old male patient visited our hospital with severe headache lasting 3 weeks.

View Article and Find Full Text PDF

Aims: Primary mucoepidermoid carcinomas (MECs) of the sinonasal tract and nasopharynx are rare entities that represent a diagnostic challenge, especially in biopsy samples. Herein, we present a case series of MECs of the sinonasal and skull base and its mimics to evaluate the clinicopathological and molecular characteristics in order to avoid misdiagnosis.

Methods: We reviewed the pathology records of patients diagnosed from 2014 to 2022.

View Article and Find Full Text PDF